Andrew Regan - Chief Executive Officer, Director, 10%+ Owner at Conduit Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director, 10%+ Owner
Stock Symbol
CDT, CDTTW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Regan since 12/6/2024

Holdings reported by Andrew Regan for Conduit Pharmaceuticals Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.12M $769K $0.69 Sep 19, 2025 Direct
Common Stock 155K $209K $1.35 Sep 19, 2025 By Manoira Corporation
Common Stock 20K $27K $1.35 Sep 19, 2025 By Corvus Capital Ltd.
Common Stock 118 $159 $1.35 Sep 19, 2025 By Algo Holdings, Inc.

Transactions reported by Andrew Regan for Conduit Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.